Antipsychotic drug-drug interactions

Antipsychotic drug-drug interactions has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jul 28, 2026: “Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort Study”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on antipsychotic drug-drug interactions

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“those with ≥ 1 DDI had a 43% increased risk of 90-day mortality (adjusted relative risk [aRR]: 1.43; 95% confidence interval [CI]: 1.22-1.69)”
Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort StudyClinical pharmacology and therapeutics2026doi:10.1002/cpt.70407
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans1

What is antipsychotic drug-drug interactions linked with?

1

Studies link antipsychotic drug-drug interactions with 1 measure, most often mortality (1 study).

Mortality

upin humans1

1 study
  1. Antipsychotic drug-drug interactions are linked with a higher risk of mortality in humans (people with dementia initiating antipsychotics) (aRR 1.43, 95% CI 1.22-1.69).

    “those with ≥ 1 DDI had a 43% increased risk of 90-day mortality (adjusted relative risk [aRR]: 1.43; 95% confidence interval [CI]: 1.22-1.69)”

    Humanspeople with dementia initiating antipsychotics90 days

    Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort Study

    Clinical pharmacology and therapeutics

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months